# PA MedTech VC Fund

> PA MedTech VC Fund is a VC fund backing Medical, Health Care and Medical Device. See 6 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Total investments: 6
- Last investment: Mar 2025
- Lead investor: 0%
- Last updated: Aug 2026

PA MedTech VC Fund is a VC fund focused on Medical and Health Care. A MedTech VC fund mainly finances start-up businesses.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 4 | 67% |
| Health Care | 4 | 67% |
| Medical Device | 4 | 67% |
| Wellness | 2 | 33% |
| Hospital | 1 | 17% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 2 | 33% |
| Series A | 1 | 17% |
| Series C | 1 | 17% |
| Series D | 1 | 17% |
| Series E | 1 | 17% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Supira Medical | Supira Medical is a clinical-stage company that develops catheter-based circulatory support devices for patients with heart conditions. Its technology is designed to provide temporary mechanical circulatory support, aiming to improve patient outcomes during high-risk procedures or acute heart failure management. The company focuses on advancingminimally invasive solutions to enhance cardiovascular care. | $120M | Series E | Mar 26, 2025 |  |
| Laza Medical | Laza Medical is a privately held startup focused on producing a high-quality AI-powered robotic imaging solution for cardiovascular treatments. | $36M | Series A | Dec 12, 2023 |  |
| Supira Medical | Supira Medical is a clinical-stage company that develops catheter-based circulatory support devices for patients with heart conditions. Its technology is designed to provide temporary mechanical circulatory support, aiming to improve patient outcomes during high-risk procedures or acute heart failure management. The company focuses on advancingminimally invasive solutions to enhance cardiovascular care. | $40M | Series D | Nov 21, 2023 |  |
| Akura Medical | Akura Medical offers products and services centered on mechanical thrombectomy and imaging software for venous thromboembolism treatment. Its Katana Thrombectomy System uses a steerable catheter with integrated jet-based technology to access clot material, break it down, and support clot removal during a procedure. The system provides proceduralfeedback intended to help clinicians assess clot engagement and clearance while operating the device. Akura Medical also develops NavIQ, a software tool that transforms CT angiograms into 3D vascular models that display clot location and morphology to guide procedural planning. Together, these products form a workflow that supports physicians from pre-procedure assessment through clot extraction in cases involving pulmonary embolism and related VTE conditions. | $35M | Series B | Oct 03, 2023 |  |
| Myra Vision | Myra Vision designs a treatment that allows maximum IOP reduction for patients with moderate to severe glaucoma. It is a privately held portfolio company of Shifamed LLC. The company accelerates its development of the first-of-its-kind treatment for patients with moderate to severe glaucoma through its latest funding. | $25M | Series B | Jun 26, 2023 |  |
| Tioga Cardiovascular | Tioga Medical, a privately held portfolio company of Shifamed LLC, is focused on providing elegant valve replacement solutions for mitral and tricuspid applications that are procedurally simpler and use a less invasive, transcatheter approach. | $30M | Series C | Feb 09, 2023 |  |

6 of 6 investments shown.

## Co-investors
- [The Capital Partnership](https://shizune.co/investors/profile/the-capital-partnership) — VC Fund, 6 deals together
- [Cormorant Asset Management](https://shizune.co/investors/profile/cormorant-asset-management) — VC Fund, 5 deals together
- [AMED Ventures](https://shizune.co/investors/profile/amed-ventures) — VC Fund, 4 deals together
- [Shifamed](https://shizune.co/investors/profile/shifamed) — VC Fund, 4 deals together
- [Unorthodox Ventures](https://shizune.co/investors/profile/unorthodox-ventures) — VC Fund, 4 deals together
- [415 Capital](https://shizune.co/investors/profile/415-capital-management) — VC Fund, 2 deals together

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does PA MedTech VC Fund invest in?

PA MedTech VC Fund invests primarily in Medical, Health Care and Medical Device startups, most often at Series B and Series A stage. Most of the 6 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did PA MedTech VC Fund last invest?

The most recent investment recorded for PA MedTech VC Fund closed in Mar 2025. Shizune tracks 6 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co